Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by Sachdev Amit, Consejero. Insider active across 3 companies, notably Vertex Pharmaceuticals INC / MA. In total, 38 disclosures have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €4.5m. History available since 17 May 2021. The latest transaction was filed on 21 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sachdev Amit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2611 títulos@ 294,33 US$4.1% de su flujoCommon StockSEC:0001209191-23-009226:0
25 de 38 declaraciones
About Sachdev Amit
Sachdev Amit is Executive Director, Chief Patient and Ext Af Off, and a director at Vertex Pharmaceuticals INC / MA, VERTEX PHARMACEUTICALS INC / MA, and a director at Eiger BioPharmaceuticals, Inc. He has 37 filings in total. Across the 37 sampled filings, the period runs from 2016-02-04 to 2026-02-26, with 0 EUR of buys and 4471086 EUR of sells, and the most frequent transaction nature is tax withholding.